HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic Acid-induced colitis in mice.

Abstract
Certain irinoid-producing plants have been used as herbal anti-inflammatory remedies. Here we evaluated whether catalposide (CATP), a single compound isolated from irinoid-producing plant Catalpa ovata, has a potential for preventing or ameliorating diseases characterized by mucosal inflammation. Preliminary microarray-based gene expression test revealed that CATP, which alone did not significantly affect expression of any of the >8,000 genes analyzed, attenuated the expression of tumor necrosis factor-alpha (TNF-alpha)-induced proinflammatory genes including interleukin-8 (IL-8) in human intestinal epithelial HT-29 cells. Down-regulation of IL-8 mRNA accumulation was also reflected by the decreased IL-8 secretion in CATP-treated HT-29 cells. The signal transduction study revealed that CATP significantly attenuates TNF-alpha-mediated p38 and extracellular signal-regulated kinase (ERK) phosphorylation. Further, CATP reduced NF-kappaB-mediated transcriptional activation as well as Ikappa-Balpha degradation. To establish the in vivo relevance of these findings, we examined whether CATP could affect intestinal inflammation in vivo using the mouse model of trinitrobenzene sulfonic acid (TNBS)-induced inflammatory colitis. Intrarectal administration of CATP dramatically reduced the weight loss, colonic damage, and mucosal ulceration that characterize TNBS colitis. Moreover, CATP suppressed the expression of TNF-alpha, interleukin-1beta, and intercellular adhesion molecule-1 along with the inhibition of NF-kappa B p65 translocation into nucleus in TNBS colitis. Collectively, current results demonstrate that CATP may be an effective agent for the treatment of diseases characterized by mucosal inflammation.
AuthorsSang-Wook Kim, Suck-Chei Choi, Eun-Young Choi, Kyoung-Suk Kim, Jae-Min Oh, Hyun-Ju Lee, Hyun-Mee Oh, Soonhag Kim, Berm-Seok Oh, Ku-Chan Kimm, Moo-Hyung Lee, Geom-Seog Seo, Tae-Hyeon Kim, Hyun-Cheol Oh, Won-Hong Woo, Youn-Seok Kim, Hyun-Ock Pae, Do-Sim Park, Hun-Taeg Chung, Chang-Duk Jun
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 10 Issue 5 Pg. 564-72 (Sep 2004) ISSN: 1078-0998 [Print] England
PMID15472516 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2004 Lippincott Williams & Wilkins
Chemical References
  • Cytokines
  • Glucosides
  • Trinitrobenzenes
  • catalposide
Topics
  • Animals
  • Colitis (drug therapy, genetics, veterinary)
  • Cytokines (analysis, biosynthesis)
  • Disease Models, Animal
  • Down-Regulation
  • Gene Expression Regulation (drug effects)
  • Glucosides (pharmacology)
  • Inflammation (genetics, pathology)
  • Intestinal Mucosa (immunology, pathology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Severity of Illness Index
  • Signal Transduction
  • Trinitrobenzenes (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: